Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers With Cardiopulmonary Disease

NCT05733767 is registered in ClinicalTrials.gov with Baystate Medical Center as lead sponsor.

NCT NCT05733767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05733767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers With Cardiopulmonary Disease
Lead sponsor
Baystate Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
November 3, 2022
Completion date
December 30, 2027
Enrollment
424 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary disease, inpatient, smoking cessation